News and publications


13 Jun 2017: Re-Pharm and Cresset Discovery Services to attend BIO International for partnering
3 Nov 2016: Re-Pharm to present at IDDST, Nanjing, China and available for one-to-one meetings, 16-19 November 2016
24 Mar 2016: Re-Pharm compound with ‘steroid-sparing properties’ granted second patent for ophthalmic indications
24 Nov 2015: Re-Pharm awarded patent for repurposed compound for treatment of inflammatory disorders
10 Feb 2015: Re-Pharm identifies novel anti-inflammatory activity for existing compound
14 May 2014: Company showcase presented at BioTrinity, London.


Publications by, or citing, Re-Pharm.

Title Author(s) Journal/Publisher/Organization Date

Empowerment of rare disease patients in modern healthcare delivery

David Cavalla Numedicus Limited 2017
Link prescriptions to medical conditions to pave the way for more repurposed drugs David Cavalla Numedicus Limited 2016
Re-Pharm eyes further advisory pitches for GBP 2.5m Series A raise for ophthalmic drug development Alexandra Thompson BioPharm Insight 2016
Re­Pharm plans GBP 2.5m Series A in 1Q16 licensing deal by 1H16 – CEO Reynald Castaneda BioPharm Insight 2015
Smart drug reprofiling Robert Scoffin BioPharma Dealmakers 2015
Substance Repurposing: Lease of Life Robert Scoffin, Alan Rothaul European Biopharmaceutical Review 2015

Repurposing: intelligent approaches

In order to develop the drug discovery market and find indications for orphan conditions, alternative methods have to be implemented. Robert Scoffin and Alan Rothaul at Re-Pharm investigate the potential of drug repurposing or re-profiling to address this issue.

Scoffin, R.; Rothaul, A. European Biopharmaceutical Review 2013

New drugs from old

Rob Scoffin explores the chemical space around existing drug molecules to provide a lower-risk, lower-cost strategy for the discovery of new chemical entities.

Scoffin, R. Innovations in Pharmaceutical Technology 2012

More reading: